What dose should be used for a G3 retroperitoneal sarcoma with R1 resection?
Would the dose change based if there was tumor adherent to bowel versus abdominal wall or muscle?
Answer from: Radiation Oncologist at Community Practice
Dose should be individualized based on location as one size would not fit all. Rcenet NCDB analysis in lancet oncology appears to show survival benefit with RT for RP sarcoma. If not in close proximity to bowel and dose to duodenum and kidneys can be kept to safe limit, then I would consider a dose ...